BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17566313)

  • 1. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
    Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
    Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
    Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
    DeQuattro V; Lee D; Messerli F
    Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ;
    Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials.
    Zou Z; Xu FY; Wang L; An MM; Zhang H; Shi XY
    J Hum Hypertens; 2011 Mar; 25(3):203-10. PubMed ID: 20535140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
    N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
    DeQuattro V; Lee D
    Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
    Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fixed combination of verapamil SR/trandolapril.
    Widimský J
    Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.